These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4278266)

  • 1. Serum inhibitory factors in cancer.
    Suciu-Foca N; Buda JA; Lo Gerfo P; Moulton A; Weber C; Wheeler B; Reemtsma K
    Oncology; 1974; 29(3):219-26. PubMed ID: 4278266
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer.
    Suciu-Foca N; Buda J; McManus J; Thiem T; Reemtsma K
    Cancer Res; 1973 Oct; 33(10):2373-7. PubMed ID: 4270240
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of water-soluble adjuvants on in vitro lymphocyte immunization.
    Sharma B; Koashi O; Mickey MR; Terasaki P
    Cancer Res; 1975 Mar; 35(3):666-9. PubMed ID: 123169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of immunology in the diagnosis and treatment of cancer.
    Humphrey LJ; Pierce GE
    Prog Clin Cancer; 1975; 6():15-36. PubMed ID: 53858
    [No Abstract]   [Full Text] [Related]  

  • 5. Humoral inhibition of the mixed lymphocyte culture response in patients with cancer.
    Eielson JA; Hattler B
    Rev Surg; 1974; 31(2):134-7. PubMed ID: 4274423
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of lymphocyte reactivity in patients with cancer, systemic lupus erythematosus and renal allografts.
    Suciu-Foca N; Herter FP; Buda JA; Reemtsma K
    Oncology; 1975; 31(3-4):125-32. PubMed ID: 127968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of destruction by lymphocytes activated in mixed leukocyte culture.
    Lightbody JJ; Bach FH
    Transplant Proc; 1972 Sep; 4(3):307-10. PubMed ID: 4263510
    [No Abstract]   [Full Text] [Related]  

  • 8. Improvement of phytohemagglutinin responsiveness of lymphocytes from cancer patients after washing in vitro.
    Mannick JA; Constantian M; Pardrige D; Saporoschetz I; Badger A
    Cancer Res; 1977 Sep; 37(9):3066-70. PubMed ID: 884664
    [No Abstract]   [Full Text] [Related]  

  • 9. Impaired in vitro cell-mediated immunity to rubella virus during pregnancy.
    Thong YH; Steele RW; Vincent MM; Hensen SA; Bellanti JA
    N Engl J Med; 1973 Sep; 289(12):604-6. PubMed ID: 4269242
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of operation on immune response in cancer patients: sequential evaluation of in vitro lymphocyte function.
    Roth JA; Golub SH; Grimm EA; Eilber FR; Morton DL
    Surgery; 1976 Jan; 79(1):46-51. PubMed ID: 128842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune response and cancer. A guide.
    Gilbert HA; Kagan AR
    Radiol Clin Biol; 1974; 43(5):409-44. PubMed ID: 4605271
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocyte micro-culture in whole blood.
    Astaldi A; Dagna Bricarelli F; Moscatelli P; Pasino M; Tassi GC; Astaldi G
    Pathologica; 1974; 66(951):69-74. PubMed ID: 4844813
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer-associated plasma proteins and lymphocyte function in patients with carcinoma.
    Kasukawa R; Masaki M; Watanabe K; Ohara M; Murai T; Yoshida T
    Fukushima J Med Sci; 1977; 24(3-4):95-106. PubMed ID: 83956
    [No Abstract]   [Full Text] [Related]  

  • 14. Common denominators of pregnancy and malignancy.
    Gleicher N; Siegel I; Francus K
    Mt Sinai J Med; 1980; 47(5):511-20. PubMed ID: 7003362
    [No Abstract]   [Full Text] [Related]  

  • 15. Mixed lymphocyte reactivity of patients with solid tumors.
    Harris J; Stewart TH
    Oncology; 1974; 30(1):33-42. PubMed ID: 4280032
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro-demonstration of cellular hypersensitivity to tumour antigens in man.
    Andersen V; Kjaer M; Bendixen G
    Ser Haematol; 1972; 5(5):3-21. PubMed ID: 4598039
    [No Abstract]   [Full Text] [Related]  

  • 17. Impaired responsiveness of lymphocytes in patients with systemic lupus erythematosus.
    Suciu-Foca N; Buda JA; Thiem T; Reemtsma K
    Clin Exp Immunol; 1974 Nov; 18(3):295-301. PubMed ID: 4283364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on cancer patients of leukapheresis with the continuous-flow blood cell separator. II. Immunologic parameters in vitro.
    Waldman SR; Roth JA; Kern DH; Pilch YH
    J Lab Clin Med; 1975 Dec; 86(6):950-61. PubMed ID: 127818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manipulation of immunologically reactive cell populations in vitro. Outline of an approach to specific immunotherapy of cancer.
    Bach ML; Bach FH; Zoschke DC
    Isr J Med Sci; 1973 Mar; 9(3):344-9. PubMed ID: 4145460
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on in vitro models of cellular immunity.
    Shacks SJ; Granger GA
    J Reticuloendothel Soc; 1971 Jul; 10(1):28-49. PubMed ID: 5121178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.